Menu
GeneBe

IDE

insulin degrading enzyme, the group of M16 metallopeptidases

Basic information

Region (hg38): 10:92451683-92574096

Links

ENSG00000119912NCBI:3416OMIM:146680HGNC:5381Uniprot:P14735AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IDE gene.

  • Inborn genetic diseases (33 variants)
  • not provided (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IDE gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
clinvar
4
missense
32
clinvar
1
clinvar
33
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 32 3 2

Variants in IDE

This is a list of pathogenic ClinVar variants found in the IDE region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-92455608-T-C not specified Likely benign (Dec 02, 2021)2355353
10-92456365-C-A not specified Uncertain significance (Nov 17, 2022)2326968
10-92456389-C-T not specified Uncertain significance (Apr 13, 2022)2402748
10-92461235-A-G not specified Uncertain significance (Aug 17, 2022)2308448
10-92463758-T-C not specified Uncertain significance (Dec 20, 2023)3108011
10-92463774-T-G not specified Uncertain significance (Nov 15, 2021)2261724
10-92463969-A-G Benign (Jul 04, 2018)773518
10-92465791-G-T Benign (Mar 30, 2018)735020
10-92465811-C-T not specified Uncertain significance (May 04, 2022)2399084
10-92468939-G-A not specified Uncertain significance (Feb 21, 2024)3108010
10-92468974-A-G not specified Uncertain significance (Nov 08, 2022)2313678
10-92468981-C-G not specified Uncertain significance (Dec 03, 2021)2264432
10-92470313-G-A not specified Uncertain significance (Feb 28, 2023)2491453
10-92470321-G-C not specified Uncertain significance (Jan 04, 2022)2349828
10-92475918-A-G not specified Uncertain significance (Feb 21, 2024)3108008
10-92475975-T-C not specified Uncertain significance (Jun 07, 2023)2558451
10-92479332-G-A not specified Uncertain significance (Feb 13, 2023)2483035
10-92479353-G-A not specified Uncertain significance (Nov 18, 2022)2327222
10-92483287-C-A not specified Uncertain significance (Aug 02, 2023)2615461
10-92487200-A-G not specified Uncertain significance (Jun 13, 2023)2525817
10-92487221-G-A not specified Uncertain significance (Mar 29, 2022)2364369
10-92490495-T-C not specified Uncertain significance (May 11, 2022)2350873
10-92490506-T-A not specified Uncertain significance (Aug 21, 2023)2592875
10-92490570-C-T not specified Uncertain significance (Nov 17, 2022)2326693
10-92490576-A-C not specified Uncertain significance (Feb 02, 2024)3108007

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IDEprotein_codingprotein_codingENST00000265986 25122393
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.006630.9931256940521257460.000207
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.083965310.7460.00002686722
Missense in Polyphen108183.070.589952350
Synonymous0.7911721860.9260.000009521834
Loss of Function5.171658.70.2730.00000301751

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004990.000489
Ashkenazi Jewish0.0004000.000397
East Asian0.0001090.000109
Finnish0.0003260.000323
European (Non-Finnish)0.0002130.000211
Middle Eastern0.0001090.000109
South Asian0.0001340.000131
Other0.0003480.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia. {ECO:0000269|PubMed:10684867, ECO:0000269|PubMed:17613531, ECO:0000269|PubMed:18986166}.;
Pathway
Alzheimer,s disease - Homo sapiens (human);Alzheimers Disease;Post-translational protein modification;Metabolism of proteins;Peroxisomal protein import;Ub-specific processing proteases;Deubiquitination (Consensus)

Recessive Scores

pRec
0.443

Intolerance Scores

loftool
0.797
rvis_EVS
-1.53
rvis_percentile_EVS
3.39

Haploinsufficiency Scores

pHI
0.838
hipred
Y
hipred_score
0.706
ghis
0.640

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.831

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ide
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); craniofacial phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
ide
Affected structure
pancreatic B cell
Phenotype tag
abnormal
Phenotype quality
decreased area

Gene ontology

Biological process
proteolysis;protein targeting to peroxisome;insulin receptor signaling pathway;determination of adult lifespan;bradykinin catabolic process;ubiquitin recycling;positive regulation of protein oligomerization;hormone catabolic process;positive regulation of protein catabolic process;negative regulation of proteolysis;viral entry into host cell;amyloid-beta metabolic process;protein homooligomerization;protein homotetramerization;protein heterooligomerization;proteolysis involved in cellular protein catabolic process;amyloid-beta clearance;insulin metabolic process;insulin catabolic process;regulation of aerobic respiration
Cellular component
extracellular space;nucleus;cytoplasm;mitochondrion;peroxisome;peroxisomal matrix;cytosol;external side of plasma membrane;cell surface;basolateral plasma membrane;cytosolic proteasome complex
Molecular function
amyloid-beta binding;virus receptor activity;metalloendopeptidase activity;signaling receptor binding;protein binding;ATP binding;zinc ion binding;ATPase activity;beta-endorphin binding;peptide binding;protein homodimerization activity;insulin binding;ubiquitin-dependent protein binding